Extract
General Electric, Celera Genomics and Celera Diagnostics Announce Broad Research Collaboration; Collaboration to Enable Development of New Approaches to Personalized Medicine.
NISKAYUNA, N.Y., ROCKVILLE, Md. & ALAMEDA, Calif. -- Initial Project to Focus on Novel Markers and Imaging Agents for Cancer
General Electric Company (NYSE:GE), through GE Global Research, along with Celera Genomics Group (NYSE:CRA), an Applera Corporation business, and Celera Diagnostics, a joint venture between Celera Genomics and the Applied Biosystems Group (NYSE:ABI) of Applera, today announced a joint research collaboration intended to accelerate the discovery and dev...See the full content of this document
Sponsored links
